Atara Biotherapeutics, Inc. (AT20) - Analysis

opens in 3d 5h 33m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,065.63 0.41%
EUR/USD 1.15 0.08%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.57 -0.06%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,065.63 0.41%
EUR/USD 1.15 0.08%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.57 -0.06%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,065.63 0.41%
EUR/USD 1.15 0.08%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.57 -0.06%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,065.63 0.41%
EUR/USD 1.15 0.08%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.57 -0.06%
XPT/USD 1,003.20 0.33%

15 EUR

0

0%

Last update Dec 30, 8:50 AM CET

Market closed

Day range

15

15

15

Previous close

15

Open

15

Access this stock data via API

Atara Biotherapeutics, Inc.

15.00

0

0%

Analysis

Analyst ratings

Firm	Date	Action
Canaccord Genuity	Jan 13, 2026	Downgrade
Canaccord Genuity	Dec 19, 2025	Maintains
Canaccord Genuity	Mar 11, 2025	Maintains
HC Wainwright & Co.	Jan 22, 2025	Reiterates
Canaccord Genuity	Jan 17, 2025	Maintains
Rodman & Renshaw	Dec 20, 2024	Initiates
Canaccord Genuity	Nov 13, 2024	Maintains
HC Wainwright & Co.	Aug 21, 2024	Reiterates
Mizuho	Aug 16, 2024	Upgrade
Canaccord Genuity	Aug 13, 2024	Maintains
Goldman Sachs	Jul 17, 2024	Maintains

Access /analyst_ratings/light data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.